Mepolizumab in corticosteroid-resistant eosinophilic asthma

Thorax

Volumn 64, Issue 6, 2009, Pages 552-

  Barratt, S ^a  

^a MUSGROVE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; MEPOLIZUMAB; PLACEBO; PREDNISOLONE;

ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORTICOSTEROID THERAPY; EOSINOPHIL COUNT; EOSINOPHILIC ASTHMA; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; UNSPECIFIED SIDE EFFECT;

EID: 67249099787     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (2)

1. Nair P, Pizzichini MMM, Kjargaard M, et al. Mepolizumab for prednisolone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-993
2. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-984